Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent.
We present a method whereby en face estimation of the chorionic capillary plexus can be generated in the living chick chorioallantoic membrane (CAM) and confirmed by post-fixation cross section analysis. This value does not alter significantly with age and provides a reliable and simple method to evaluate anti-angiogenesis. Anti-angiogenesis may be induced by an intervention, such as a pharmacological agent, applied to the surface of the CAM. We describe the use of silastic rings that are associated with minimal inflammatory reaction, in this process. By estimating changes in the chorionic capillary plexus to quantify anti-angiogenesis, together with silastic rings, we examined the anti-angiogenic effect of human angiostatin and demonstrated that although there is a significant loss of capillaries en face after exposure from days 7 to 9 of incubation, in contrast there is no significant inhibition after exposure to a similar dose of angiostatin from days 11 to 13 of incubation. This not only demonstrates the important effects on neo-angiogenesis compared to mature vessels, but also illustrates the potential of the CAM to readily provide a means for such a comparison.
Seidlitz
Eric
E
Juravinski Cancer Centre, Hamilton, Ontario, Canada.
Korbie
Darren
D
Marien
Lindsay
L
Richardson
Mary
M
Singh
Gurmit
G
D000367:Age Factors; D000482:Allantois / Q000098:blood supply / Q000187:drug effects*; D043168:Angiostatins / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002196:Capillaries / Q000187:drug effects; D002642:Chick Embryo; D002823:Chorion / Q000098:blood supply / Q000187:drug effects*; D004129:Dimethylpolysiloxanes; D004337:Drug Carriers; D004343:Drug Implants; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D018715:Microscopy, Video; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D012828:Silicones; D012996:Solutions / Q000494:pharmacology
D004129:Dimethylpolysiloxanes; D004337:Drug Carriers; D004343:Drug Implants; D012828:Silicones; D012996:Solutions; C013830:baysilon; D043168:Angiostatins; D005947:Glucose